Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats

NeuroImage

Volumn 36, Issue 3, 2007, Pages 755-773

  Yang, J ^a,c   Sadler, T R ^a   Givrad, T K ^b   Maarek, J M I ^b   Holschneider, D P ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b California School of Engineering ^*  (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Brain mapping; Cerebral blood flow; Functional neuroimaging; Hemiparkinsonism; Parkinson's Disease; Plasticity

Indexed keywords

IODOPHENAZONE C 14; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN DAMAGE; BRAIN FUNCTION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOTOR CORTEX; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; RED NUCLEUS; STATISTICAL ANALYSIS; SUBICULUM; SUBTHALAMIC NUCLEUS; THALAMUS; WALKING;

AMPHETAMINE; ANIMALS; AUTORADIOGRAPHY; BRAIN; BRAIN DAMAGE, CHRONIC; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBELLUM; FUNCTIONAL LATERALITY; GLOBUS PALLIDUS; IMAGE PROCESSING, COMPUTER-ASSISTED; LOCOMOTION; MALE; MODELS, NEUROLOGICAL; NEOSTRIATUM; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; REST; SUBTHALAMIC NUCLEUS; TYROSINE 3-MONOOXYGENASE; WALKING;

EID: 34250169757     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.03.010     Document Type: Article

References (103)

1. Albani G., Kunig G., Soelch C.M., Mauro A., Priano L., Martignoni E., and Leenders K.L. The role of language areas in motor control dysfunction in Parkinson's disease. Neurol. Sci. 22 (2001) 43-44
2. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 (1989) 366-375
3. Alexander G.E., and Crutcher M.D. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13 (1990) 266-271
4. Alexander G.E., Crutcher M.D., and DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog. Brain Res. 85 (1990) 119-146
5. Bergman H., Wichmann T., and DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249 (1990) 1436-1438
6. Bezard E., Boraud T., Bioulac B., and Gross C.E. Presymptomatic revelation of experimental parkinsonism. NeuroReport 8 (1997) 435-438
7. Bezard E., Gross C.E., and Brotchie J.M. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci. 26 (2003) 215-221
8. Boecker H., Ceballos-Baumann A., Bartenstein P., Weindl A., Siebner H.R., Fassbender T., Munz F., Schwaiger M., and Conrad B. Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET. Brain 122 Pt. 9 (1999) 1651-1665
9. Burns L.H., Annett L., Kelley A.E., Everitt B.J., and Robbins T.W. Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: implication for limbic-striatal interactions. Behav. Neurosci. 110 (1996) 60-73
10. Cadet J.L., Last R., Kostic V., Przedborski S., and Jackson-Lewis V. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen. Brain Res. Bull. 26 (1991) 707-713
11. Caine S.B., Humby T., Robbins T.W., and Everitt B.J. Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotion, cocaine self- administration, and prepulse inhibition of startle. Behav. Neurosci. 115 (2001) 880-894
12. Castellano M.A., and Rodriguez Diaz M. Nigrostriatal dopaminergic cell activity is under control by substantia nigra of the contralateral brain side: electrophysiological evidence. Brain Res. Bull. 27 (1991) 213-218
13. Catalan M.J., Ishii K., Honda M., Samii A., and Hallett M. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 122 Pt. 3 (1999) 483-495
14. Cohen A.D., Tillerson J.L., Smith A.D., Schallert T., and Zigmond M.J. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J. Neurochem. 85 (2003) 299-305
15. Dahlgren N., Lindvall O., Nobin A., and Stenevi U. Cerebral circulatory response to hypercapnia: effects of lesions of central dopaminergic and serotoninergic neuron systems. Brain Res. 230 (1981) 221-233
16. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13 (1990) 281-285
17. DeLong M.R., and Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch. Neurol. 64 (2007) 20-24
18. DiMattia B.V., and Kesner R.P. Role of the posterior parietal association cortex in the processing of spatial event information. Behav. Neurosci. 102 (1988) 397-403
19. Doudet D.J., Gross C., Arluison M., and Bioulac B. Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons. Exp. Brain Res. 80 (1990) 177-188
20. Dunnett S.B., Meldrum A., and Muir J.L. Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat. Neuroscience 135 (2005) 1055-1065
21. Erro M.E., Lanciego J.L., Arribas J., and Gimenez-Amaya J.M. Striatal input from the ventrobasal complex of the rat thalamus. Histochem. Cell Biol. 115 (2001) 447-454
22. Foley P., and Riederer P. Pathogenesis and preclinical course of Parkinson's disease. J. Neural Transm., Suppl. 56 (1999) 31-74
23. Friston K.J. Commentary and opinion: II. Statistical parametric mapping: ontology and current issues. J. Cereb. Blood Flow Metab. 15 (1995) 361-370
24. Friston K.J., Frith C.D., Liddle P.F., Dolan R.J., Lammertsma A.A., and Frackowiak R.S. The relationship between global and local changes in PET scans. J. Cereb. Blood Flow Metab. 10 (1990) 458-466
25. Fukuyama H., Ouchi Y., Matsuzaki S., Nagahama Y., Yamauchi H., Ogawa M., Kimura J., and Shibasaki H. Brain functional activity during gait in normal subjects: a SPECT study. Neurosci. Lett. 228 (1997) 183-186
26. Gesi M., Soldani P., Giorgi F.S., Santinami A., Bonaccorsi I., and Fornai F. The role of the locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev. 24 (2000) 655-668
27. Goldberg J.A., Boraud T., Maraton S., Haber S.N., Vaadia E., and Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J. Neurosci. 22 (2002) 4639-4653
28. Goldman H., and Sapirstein L.A. Brain blood flow in the conscious and anesthetized rat. Am. J. Physiol. 224 (1973) 122-126
29. Graybiel A.M. Some fiber pathways related to the posterior thalamic region in the cat. Brain Behav. Evol. 6 (1972) 363-393
30. Groenewegen H.J., and Witter M.P. Thalamus, G. Paxinos, The Rat Nervous System (2004), Elsevier Academic Press, San Diego 407-453
31. Gsell W., De Sadeleer C., Marchalant Y., MacKenzie E.T., Schumann P., and Dauphin F. The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations. J. Chem. Neuroanat. 20 (2000) 215-224
32. Hanakawa T., Fukuyama H., Katsumi Y., Honda M., and Shibasaki H. Enhanced lateral premotor activity during paradoxical gait in Parkinson's disease. Ann. Neurol. 45 (1999) 329-336
33. Hardman C.D., Henderson J.M., Finkelstein D.I., Horne M.K., Paxinos G., and Halliday G.M. Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei. J. Comp. Neurol. 445 (2002) 238-255
34. Harik S.I., LaManna J.C., Snyder S., Wetherbee J.R., and Rosenthal M. Abnormalities of cerebral oxidative metabolism in animal models of Parkinson disease. Neurology 32 (1982) 382-389
35. Hattori S., Naoi M., and Nishino H. Striatal dopamine turnover during treadmill running in the rat: relation to the speed of running. Brain Res. Bull. 35 (1994) 41-49
36. Hays W. Statistics for the Social Sciences, 2nd (1973), Holt, Rinehart & Winston, New York
37. Heise C.E., and Mitrofanis J. Evidence for a glutamatergic projection from the zona incerta to the basal ganglia of rats. J. Comp. Neurol. 468 (2004) 482-495
38. Henderson J.M., Pell M., O'Sullivan D.J., McCusker E.A., Fung V.S., Hedges P., and Halliday G.M. Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease. Mov. Disord. 17 (2002) 133-137
39. Hermer-Vazquez L., Hermer-Vazquez R., Moxon K.A., Kuo K.H., Viau V., Zhan Y., and Chapin J.K. Distinct temporal activity patterns in the rat M1 and red nucleus during skilled versus unskilled limb movement. Behav. Brain Res. 150 (2004) 93-107
40. Holschneider D.P., and Scremin O.U. Effects of ovariectomy on cerebral flow of rats. Neuroendocrinology 67 (1998) 260-268
41. Holschneider D.P., Maarek J.M., Harimoto J., Yang J., and Scremin O.U. An implantable bolus infusion pump for use in freely moving, nontethered rats. Am. J. Physiol.: Heart Circ. Physiol. 283 (2002) H1713-H1719
42. Holschneider D.P., Maarek J.M., Yang J., Harimoto J., and Scremin O.U. Functional brain mapping in freely moving rats during treadmill walking. J. Cereb. Blood Flow Metab. 23 (2003) 925-932
43. Ichitani Y., Okamura H., Nakahara D., Nagatsu I., and Ibata Y. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra. Exp. Neurol. 130 (1994) 269-278
44. Ingvar M., Lindvall O., and Stenevi U. Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle. Brain Res. 262 (1983) 259-265
45. Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., and Brooks D.J. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118 Pt. 4 (1995) 913-933
46. Jasmin L., Gogas K.R., Ahlgren S.C., Levine J.D., and Basbaum A.I. Walking evokes a distinctive pattern of Fos-like immunoreactivity in the caudal brainstem and spinal cord of the rat. Neuroscience 58 (1994) 275-286
47. Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S., Passingham R.E., and Brooks D.J. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann. Neurol. 32 (1992) 749-757
48. Jones S.C., Korfali E., and Marshall S.A. Cerebral blood flow with the indicator fractionation of [14C]iodoantipyrine: effect of PaCO2 on cerebral venous appearance time. J. Cereb. Blood Flow Metab. 11 (1991) 236-241
49. Keri S., and Gulyas B. Four facets of a single brain: behaviour, cerebral blood flow/metabolism, neuronal activity and neurotransmitter dynamics. NeuroReport 14 (2003) 1097-1106
50. Kolb B., Sutherland R.J., and Whishaw I.Q. A comparison of the contributions of the frontal and parietal association cortex to spatial localization in rats. Behav. Neurosci. 97 (1983) 13-27
51. Kotter R., and Feizelmeier M. Species-dependence and relationship of morphological and electrophysiological properties in nigral compacta neurons. Prog. Neurobiol. 54 (1998) 619-632
52. Lavoie S., and Drew T. Discharge characteristics of neurons in the red nucleus during voluntary gait modifications: a comparison with the motor cortex. J. Neurophysiol. 88 (2002) 1791-1814
53. Lee J.S., Ahn S.H., Lee D.S., Oh S.H., Kim C.S., Jeong J.M., Park K.S., Chung J.K., and Lee M.C. Voxel-based statistical analysis of cerebral glucose metabolism in the rat cortical deafness model by 3D reconstruction of brain from autoradiographic images. Eur. J. Nucl. Med. Mol. Imaging 32 (2005) 696-701
54. Lees A.J. When did Ray Kennedy's Parkinson's disease begin?. Mov. Disord. 7 (1992) 110-116
55. Lindvall O., Ingvar M., and Stenevi U. Effects of methamphetamine on blood flow in the caudate-putamen after lesions of the nigrostriatal dopaminergic bundle in the rat. Brain Res. 211 (1981) 211-216
56. Ma J., Brudzynski S.M., and Leung L.W. A role of subicular and hippocampal afterdischarges in initiation of locomotor activity in rats. Brain Res. 793 (1998) 112-118
57. Massopust L.C., Hauge D.H., Ferneding J.C., Doubek W.G., and Taylor J.J. Projection systems and terminal localization of dorsal column afferents: an autoradiographic and horseradish peroxidase study in the rat. J. Comp. Neurol. 237 (1985) 533-544
58. Medina L., and Reiner A. Neurotransmitter organization and connectivity of the basal ganglia in vertebrates: implications for the evolution of basal ganglia. Brain Behav. Evol. 46 (1995) 235-258
59. Meissner W., Ravenscroft P., Reese R., Harnack D., Morgenstern R., Kupsch A., Klitgaard H., Bioulac B., Gross C.E., Bezard E., and Boraud T. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiol. Dis. 22 (2006) 586-598
60. Metz G.A., Piecharka D.M., Kleim J.A., and Whishaw I.Q. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease. Brain Res. 1026 (2004) 126-135
61. Moore W.H., Holschneider D.P., Givrad T.K., and Maarek J.-M.I. Transcutaneous RF- Powered implantable minipump driven by a class-E transmitter. IEEE Trans. Biomed. Eng. 53 (2006) 1-3
62. Morgan S., and Huston J.P. The interhemispheric projection from the substantia nigra to the caudate-putamen as depicted by the anterograde transport of [3H]leucine. Behav. Brain Res. 38 (1990) 155-162
63. Mraovitch S., Calando Y., Onteniente B., Peschanski M., and Seylaz J. Cerebrovascular and metabolic uncoupling in the caudate-putamen following unilateral lesion of the mesencephalic dopaminergic neurons in the rat. Neurosci. Lett. 157 (1993) 140-144
64. Nguyen P.T., Holschneider D.P., Maarek J.M., Yang J., and Mandelkern M.A. Statistical parametric mapping applied to an autoradiographic study of cerebral activation during treadmill walking in rats. NeuroImage 23 (2004) 252-259
65. Nicholson S.L., and Brotchie J.M. 5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease-Opportunities for novel therapeutics to reduce the problems of levodopa therapy. Eur. J. Neurol. 9 Suppl. 3 (2002) 1-6
66. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Macias R., Alvarez L., Guridi J., Vitek J., and DeLong M.R. Pathophysiologic basis of surgery for Parkinson's disease. Neurology 55 (2000) S7-S12
67. Obeso J.A., Rodriguez-Oroz M.C., Lanciego J.L., and Rodriguez Diaz M. How does Parkinson's disease begin? The role of compensatory mechanisms. Trends Neurosci. 27 (2004) 125-127 (author reply 127-128)
68. Pan W.X., and McNaughton N. The supramammillary area: its organization, functions and relationship to the hippocampus. Prog. Neurobiol. 74 (2004) 127-166
69. Patlak C.S., Blasberg R.G., and Fenstermacher J.D. An evaluation of errors in the determination of blood flow by the indicator fractionation and tissue equilibration (Kety) methods. J. Cereb. Blood Flow Metab. 4 (1984) 47-60
70. Paxinos G., and Watson C. The Rat Brain in Stereotactic Coordinates. 5th edition (2005), Elsevier Academic Press, New York, NY
71. Pelled G., Bergman H., and Goelman G. Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease-A functional magnetic resonance imaging study. Eur. J. Neurosci. 15 (2002) 389-394
72. Perier C., Agid Y., Hirsch E.C., and Feger J. Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion. NeuroReport 11 (2000) 3275-3278
73. Perier C., Vila M., Feger J., Agid Y., and Hirsch E.C. Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats. Exp. Neurol. 162 (2000) 215-224
74. Playford E.D., Jenkins I.H., Passingham R.E., Nutt J., Frackowiak R.S., and Brooks D.J. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann. Neurol. 32 (1992) 151-161
75. Rascol O., Sabatini U., Chollet F., Celsis P., Montastruc J.L., Marc-Vergnes J.P., and Rascol A. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch. Neurol. 49 (1992) 144-148
76. Rascol O., Sabatini U., Chollet F., Fabre N., Senard J.M., Montastruc J.L., Celsis P., Marc-Vergnes J.P., and Rascol A. Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. J. Neurol., Neurosurg. Psychiatry 57 (1994) 567-571
77. Rascol O., Sabatini U., Fabre N., Brefel C., Loubinoux I., Celsis P., Senard J.M., Montastruc J.L., and Chollet F. The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 120 Pt. 1 (1997) 103-110
78. Rascol O., Sabatini U., Brefel C., Fabre N., Rai S., Senard J.M., Celsis P., Viallard G., Montastruc J.L., and Chollet F. Cortical motor overactivation in parkinsonian patients with l-dopa-induced peak-dose dyskinesia. Brain 121 Pt. 3 (1998) 527-533
79. Risold P.Y., and Swanson L.W. Chemoarchitecture of the rat lateral septal nucleus. Brain Res. Brain Res. Rev. 24 (1997) 91-113
80. Roedter A., Winkler C., Samii M., Walter G.F., Brandis A., and Nikkhah G. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J. Comp. Neurol. 432 (2001) 217-229
81. Ruigrok T.J. Precerebellar nuclei and red nucleus. In: Paxinos G. (Ed). The Rat Nervous System (2004), Elsevier Academic Press, San Diego 167-204
82. Ruigrok T.J., van der Burg H., and Sabel-Goedknegt E. Locomotion coincides with c-Fos expression in related areas of inferior olive and cerebellar nuclei in the rat. Neurosci. Lett. 214 (1996) 119-122
83. Sabatini U., Boulanouar K., Fabre N., Martin F., Carel C., Colonnese C., Bozzao L., Berry I., Montastruc J.L., Chollet F., and Rascol O. Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 123 Pt. 2 (2000) 394-403
84. Sabol K.E., Richards J.B., and Freed C.R. In vivo dialysis measurements of dopamine and DOPAC in rats trained to turn on a circular treadmill. Pharmacol. Biochem. Behav. 36 (1990) 21-28
85. Saint-Cyr J.A., and Woodward D.J. A topographic analysis of limbic and somatic inputs to the cerebellar cortex in the rat. Exp. Brain Res. 40 (1980) 13-22
86. Sakurada O., Kennedy C., Jehle J., Brown J.D., Carbin G.L., and Sokoloff L. Measurement of local cerebral blood flow with iodo [14C] antipyrine. Am. J. Physiol. 234 (1978) H59-H66
87. Samuel M., Ceballos-Baumann A.O., Blin J., Uema T., Boecker H., Passingham R.E., and Brooks D.J. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 120 Pt. 6 (1997) 963-976
88. Santori E.M., Der T., and Collins R.C. Functional metabolic mapping during forelimb movement in rat. II. Stimulation of forelimb muscles. J. Neurosci. 6 (1986) 463-474
89. Sauer H., and Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59 (1994) 401-415
90. Schallert T., Leasure J.L., and Kolb B. Experience-associated structural events, subependymal cellular proliferative activity, and functional recovery after injury to the central nervous system. J. Cereb. Blood Flow Metab. 20 (2000) 1513-1528
91. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
92. Schwarting R.K., and Huston J.P. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog. Neurobiol. 49 (1996) 215-266
93. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50 (1996) 275-331
94. Smeets W.J., Marin O., and Gonzalez A. Evolution of the basal ganglia: new perspectives through a comparative approach. J. Anat. 196 Pt. 4 (2000) 501-517
95. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9 (1982) 321-353
96. Taepavarapruk P., Floresco S.B., and Phillips A.G. Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: role of ionotropic glutamate and dopamine D1 receptors. Psychopharmacology (Berlin) 151 (2000) 242-251
97. Taghzouti K., Simon H., Tazi A., Dantzer R., and Le Moal M. The effect of 6-OHDA lesions of the lateral septum on schedule-induced polydipsia. Behav. Brain Res. 15 (1985) 1-8
98. Thevenaz P., Ruttimann U.E., and Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Process. 7 (1998) 27-41
99. Thobois S., Dominey P., Decety J., Pollak P., Gregoire M.C., and Broussolle E. Overactivation of primary motor cortex is asymmetrical in hemiparkinsonian patients. NeuroReport 11 (2000) 785-789
100. Van Uitert R.L., and Levy D.E. Regional brain blood flow in the conscious gerbil. Stroke 9 (1978) 67-72
101. Voges J., Volkmann J., Allert N., Lehrke R., Koulousakis A., Freund H.J., and Sturm V. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J. Neurosurg. 96 (2002) 269-279
102. Waite J.J., Holschneider D.P., and Scremin O.U. Selective immunotoxin-induced cholinergic deafferentation alters blood flow distribution in the cerebral cortex. Brain Res. 818 (1999) 1-11
103. Yuan H., Sarre S., Ebinger G., and Michotte Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J. Neurosci. Methods 144 (2005) 35-45